The Gross Margin of Bridge Biotherapeutics Inc (288330.KQ) is 33.33%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 33.33% |
| 2022-12-31 | 99.40% |
| 2021-12-31 | 39.37% |
| 2020-12-31 | -17.56% |
| 2019-12-31 | 38.24% |